Xywav or Xyrem: What’s the Difference?
The FDA approved a new oxybate formulation for excessive daytime sleepiness or cataplexy in narcolepsy. Should your patients switch?
Read More
Author: Sree Roy
Investigational Insomnia Drug Improves Daytime Functioning in Phase 3 Study
A new patient-reported outcome instrument was developed to assess daytime functioning in patients with insomnia and Idorsia included it in daridorexant’s Phase 3 program.
Read More
5 Items Physicians Should Question on Pediatric Sleep & Pulmonology
The AAP released a list of therapies and practices for treating sleep disorders and asthma that should be considered before being used with children.
Read More
Does the ‘Caff-Nap’ Work for Shift Workers?
Many workers nap during a night shift, but they can experience sleep inertia—that grogginess just after awakening.
Read More
Large Study Finds Narcolepsy Drug Does Not Up Risk of Fetal Malformation
A registry study involving 2 million pregnant women shows no association between modafinil and an increased risk of malformation in babies.
Read More